{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_16712", "batch_size": 200, "batch_pos": 22, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "The segment neutrally states deal details.", "method": "llm_batch", "batch_id": "batch_2_16252", "batch_size": 200, "batch_pos": 198, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "The verbs 'secures' and 'includes' are not on the list of moderate verbs.", "method": "llm_batch", "batch_id": "batch_3_5548", "batch_size": 200, "batch_pos": 160, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_21392", "batch_size": 200, "batch_pos": 158, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "The segment reports factual details about a deal but contains no explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_19492", "batch_size": 200, "batch_pos": 155, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "Segment does not contain a minimiser combined with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_14760", "batch_size": 200, "batch_pos": 120, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "Segment contains no bare negation.", "method": "llm_batch", "batch_id": "batch_7_14940", "batch_size": 200, "batch_pos": 112, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "yes", "rationale": "Describes the terms of a deal ('secures up to 665,000 doses', 'includes an option for a further 40 million vaccines'), which relates to vaccine procurement/preparedness.", "method": "llm_batch", "batch_id": "batch_8_19156", "batch_size": 200, "batch_pos": 154, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
